Prevention of severe nocturnal hypoxemia in COPD patients at high altitude. (Results of a randomized controlled trial)
Journal of Respiratory Medicine · 17.04.2026 · 2 (1) · 7
DOI: 10.17116/respmed202620117 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Respiratory Medicine, erschienen am 17.04.2026. Verfasst von M.Zh. Mademilov und 5 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Objective. To assess the efficacy of acetazolamide in preventing severe nocturnal hypoxemia in patients with chronic obstructive pulmonary disease (COPD) during a short-term stay at an altitude of 3100 m. Material and methods. In a randomized, double-blind, placebo-controlled trial, 176 patients with COPD (FEV1 40—80% of predicted, SpO2≥92%, PaCO2
Zitieren
APA
Mademilov, M., Taalaibekova, A., Mirzalieva, G., Magdieva, K., Omuralieva, A., & Sooronbaev, T. (2026). Prevention of severe nocturnal hypoxemia in COPD patients at high altitude. (Results of a randomized controlled trial). Journal of Respiratory Medicine, 2(1), 7. https://doi.org/10.17116/respmed202620117
Vancouver
Mademilov M, Taalaibekova A, Mirzalieva G, Magdieva K, Omuralieva A, Sooronbaev T. Prevention of severe nocturnal hypoxemia in COPD patients at high altitude. (Results of a randomized controlled trial). Journal of Respiratory Medicine. 2026;2(1):7. doi:10.17116/respmed202620117
BibTeX
@article{Mademilov2026,
author = {Mademilov, M.Zh. and Taalaibekova, A.T. and Mirzalieva, G.M. and Magdieva, K.M. and Omuralieva, A.K. and Sooronbaev, T.M.},
title = {Prevention of severe nocturnal hypoxemia in COPD patients at high altitude. (Results of a randomized controlled trial)},
journal = {Journal of Respiratory Medicine},
year = {2026},
volume = {2},
number = {1},
pages = {7},
doi = {10.17116/respmed202620117}
}
EUVIMED